Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Extended genetic testing and GYN cancer risk

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.07.18
Views: 271
Rating:

Dr Zoe Kemp - The Royal Marsden NHS Foundation Trust, London, UK

Dr Kemp speaks with ecancer at BCGS 2018 about determining inherited risks to ovarian cancer.

She outlines the availability of genetic screening for patients and their family, and the overlap with genetic screening programmes for breast cancer.

Dr Kemp notes the importance of testing beyond BRCA mutations, highlighting Lynch Syndrome and its associated diseases.

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation